Style | Citing Format |
---|---|
MLA | Rahimifard M, et al.. "Combination Therapy of Cisplatin and Resveratrol to Induce Cellular Aging in Gastric Cancer Cells: Focusing on Oxidative Stress, and Cell Cycle Arrest." Frontiers in Pharmacology, vol. 13, no. , 2023, pp. -. |
APA | Rahimifard M, Baeeri M, Mousavi T, Azarnezhad A, Haghiaminjan H, Abdollahi M (2023). Combination Therapy of Cisplatin and Resveratrol to Induce Cellular Aging in Gastric Cancer Cells: Focusing on Oxidative Stress, and Cell Cycle Arrest. Frontiers in Pharmacology, 13(), -. |
Chicago | Rahimifard M, Baeeri M, Mousavi T, Azarnezhad A, Haghiaminjan H, Abdollahi M. "Combination Therapy of Cisplatin and Resveratrol to Induce Cellular Aging in Gastric Cancer Cells: Focusing on Oxidative Stress, and Cell Cycle Arrest." Frontiers in Pharmacology 13, no. (2023): -. |
Harvard | Rahimifard M et al. (2023) 'Combination Therapy of Cisplatin and Resveratrol to Induce Cellular Aging in Gastric Cancer Cells: Focusing on Oxidative Stress, and Cell Cycle Arrest', Frontiers in Pharmacology, 13(), pp. -. |
Vancouver | Rahimifard M, Baeeri M, Mousavi T, Azarnezhad A, Haghiaminjan H, Abdollahi M. Combination Therapy of Cisplatin and Resveratrol to Induce Cellular Aging in Gastric Cancer Cells: Focusing on Oxidative Stress, and Cell Cycle Arrest. Frontiers in Pharmacology. 2023;13():-. |
BibTex | @article{ author = {Rahimifard M and Baeeri M and Mousavi T and Azarnezhad A and Haghiaminjan H and Abdollahi M}, title = {Combination Therapy of Cisplatin and Resveratrol to Induce Cellular Aging in Gastric Cancer Cells: Focusing on Oxidative Stress, and Cell Cycle Arrest}, journal = {Frontiers in Pharmacology}, volume = {13}, number = {}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Rahimifard M AU - Baeeri M AU - Mousavi T AU - Azarnezhad A AU - Haghiaminjan H AU - Abdollahi M TI - Combination Therapy of Cisplatin and Resveratrol to Induce Cellular Aging in Gastric Cancer Cells: Focusing on Oxidative Stress, and Cell Cycle Arrest JO - Frontiers in Pharmacology VL - 13 IS - SP - EP - PY - 2023 ER - |